Publication:
Clinical utility of intralesional methotrexate to distinguish crateriform keratinocytic tumors before surgery.

dc.contributor.authorSalido-Vallejo, Rafael
dc.contributor.authorSanz-Cabanillas, Juan Luis
dc.contributor.authorNúñez-Córdoba, Jorge María
dc.contributor.authorGonzález-Menchen, Alberto
dc.contributor.authorVelez Garcia-Nieto, Antonio
dc.contributor.authorRedondo, Pedro
dc.date.accessioned2023-05-03T13:28:43Z
dc.date.available2023-05-03T13:28:43Z
dc.date.issued2021-12-21
dc.identifier.citationSalido-Vallejo R, Sanz-Cabanillas JL, Núñez-Córdoba JM, González-Menchen A, Vélez A, Redondo P. Clinical utility of intralesional methotrexate to distinguish crateriform keratinocytic tumors before surgery. J Dtsch Dermatol Ges. 2022 Jan;20(1):102-105.
dc.identifier.doi10.1111/ddg.14637
dc.identifier.essn1610-0387
dc.identifier.pmid34932272
dc.identifier.urihttp://hdl.handle.net/10668/19933
dc.issue.number1
dc.journal.titleJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
dc.journal.titleabbreviationJ Dtsch Dermatol Ges
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.page.number102-105
dc.pubmedtypeLetter
dc.subject.decsBiopsia
dc.subject.decsCarcinoma
dc.subject.decsCirugía General
dc.subject.decsCélulas Epiteliales
dc.subject.decsPronóstico
dc.subject.decsMetotrexato
dc.subject.decsNeoplasias
dc.subject.meshHumans
dc.subject.meshInjections, Intralesional
dc.subject.meshKeratinocytes
dc.subject.meshKeratoacanthoma
dc.subject.meshMethotrexate
dc.subject.meshNeoplasms
dc.titleClinical utility of intralesional methotrexate to distinguish crateriform keratinocytic tumors before surgery.
dc.typeresearch article
dc.volume.number20
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
SalidoVallejo_Clinical.pdf
Size:
512.35 KB
Format:
Adobe Portable Document Format